Insmed | Marketskapitalisme



Market Capitalization Endring Dato
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Cytokinetics USD 5.55B 661M 2024-12
DBV Technologies USD 79M 5M 2024-09
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
Insmed USD 12.35B 194M 2024-12
Novartis USD 230.87B 3.48B 2024-09
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



Insmed Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.